Abstract
Glycine N-methyltransferase is a protein with many functions. In addition to catalyzing the production of sarcosine in the one carbon metabolism pathway, it plays a role in the detoxification of environmental carcinogens such as benzo[a]pyrene, aflatoxin B1, and aristocholic acid. There is also increasing evidence suggesting a role of GNMT deficiency in liver carcinogenesis. In this review, we discuss the role of GNMT in the detoxification of xenobiotics and the mechanism of GNMT suppression during liver tumorigenesis. The protective role of GNMT in the liver allows GNMT to not only serve as a marker of liver disease, but also potentially be applied in the treatment of liver disorders and hepatocellular carcinoma. We describe the potential use of GNMT in gene therapy and we introduce the development of a GNMT promoter reporter assay that can be used to screen medicinal drugs and herbal libraries for natural compounds with anti-cancer properties.
| Original language | English |
|---|---|
| Article number | 114607 |
| Journal | Toxicology and Applied Pharmacology |
| Volume | 378 |
| DOIs | |
| Publication status | Published - Sept 1 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Detoxification
- Drug screening
- Gene therapy
- Glycine N-methyltransferase
- Hepatocellular carcinoma
ASJC Scopus subject areas
- Toxicology
- Pharmacology
Fingerprint
Dive into the research topics of 'Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS